Carbetocin
ACP-101-303
Phase 3 small_molecule active
Quick answer
Carbetocin for Hyperphagia in Prader-Willi Syndrome is a Phase 3 program (small_molecule) at Acadia Pharmaceuticals B.V. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Acadia Pharmaceuticals B.V.
- Indication
- Hyperphagia in Prader-Willi Syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active